Biomatter
Biomatter is a deep-tech synthetic biology company that pioneered the use of generative AI for de novo protein design.
About
Biomatter is a deep-tech synthetic biology company that pioneered the use of generative AI for de novo protein design. Their Intelligent Architecture™ platform allows scientists to design enzymes from the "bottom-up"—starting with the desired function rather than modifying existing natural templates. By combining generative models with physics-based engines, they create "new-to-nature" proteins for healthcare, agriculture, and sustainable manufacturing. The platform significantly reduces development cycles from years to weeks. In 2019, they published the first functional enzymes created by AI in Nature Machine Intelligence and recently became the first Baltic company to join the AstraZeneca BioVentureHub.
Ready to look at your business the way a machine would?
Whether you are launching or scaling, the first conversation is free.